Latest Memorial Sloan–Kettering Cancer Center Stories
Hands On HealthCare Massage Therapy and Wellness Day Spa is raising awareness and funds during September, National
On September 27, the Mesothelioma Applied Research Foundation will be the host of its “Knowledge is Hope” regional conference on malignant mesothelioma, taking place at the Harvard Club in
A new study by thoracic surgeons and pathologists at Memorial Sloan-Kettering Cancer Center shows that a specific pattern found in the tumor pathology of some lung cancer patients is a strong predictor of recurrence.
The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma.
The Society for Translational Oncology (STO) is pleased to announce that Professor Patrick G.
The Cancer Research Institute (CRI) declares June “Cancer Immunotherapy Awareness Month” to increase awareness of cancer immunotherapy, a new class of cancer treatment that mobilizes the immune
- a slit in a tire to drain away surface water and improve traction.